American Society of Addiction Medicine

This Week in Addiction Medicine from ASAM

American Society of Addiction Medicine

  • Lead Story: A neuromarker for drug and food craving distinguishes drug users from non-users

Lead Story: A neuromarker for drug and food craving distinguishes drug users from non-users

Tuesday 10th January 2023

Learn about a neuromarker that identifies drug users by their brain patterns and more in this episode of 'Addiction Medicine Unpacked'.
7 minutes
Informative
Empowering
Hopeful
Educational
Thought-provoking

About this podcast

This Week in Addiction Medicine from ASAM
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Rounded Button Dark
Do you want to link to this podcast?
Get the buttons here!

Brain Patterns: How Cravings Differentiate Drug Users from Non-Users

The Neurobiological Craving Signature has promise for diagnosing substance use disorder as well as measuring responses to treatment.
Ever wondered if there's a way to see how cravings for drugs and food light up the brain? This episode of 'Addiction Medicine Unpacked' from ASAM dives into groundbreaking research that uses functional MRI and machine learning to identify a neuromarker called the Neurobiological Craving Signature (NCS). This NCS can distinguish between drug users and non-users with an impressive 82% accuracy.
Whether it's cravings for drugs like cocaine, alcohol, or even just palatable foods, this episode reveals how similar these brain patterns are. It's a fascinating look at how our brains react to different types of cravings and what this could mean for diagnosing substance use disorders and measuring treatment responses. But that's not all. The episode also covers a variety of other intriguing topics in addiction medicine.
You'll hear about the impact of white matter tracts on heroin addiction, the effects of buprenorphine on opioid cravings, and the consequences of in-utero exposure to cannabinoids. It doesn't stop there - the discussion extends to COVID-19's link with endocarditis in patients using opioids or stimulants, the mortality risk following non-fatal injuries involving alcohol use disorder, and even the unintended effects of e-cigarette taxes on youth tobacco use.
For anyone touched by addiction or working in the field, this episode is packed with valuable insights and current research findings. Tune in for an engaging mix of science and real-world implications that could change how we understand and treat addiction.
alcoholfree.com
Published by The Mindful Drinking Company Limited
4 Providence Court, Pynes Hill, Exeter, Devon, EX2 5JL, England
Registered in England and Wales.
Company Number: 1195057. Vat Number: GB320915135.
Registered address as above.
© Copyright 2005-2025 The Mindful Drinking Company Limited.
All Rights Reserved.
alcoholfree.com is a participant in the Amazon Associates Programme, an affiliate advertising programme designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.co.uk. As an Amazon Associate, we earn from qualifying purchases.